HealthEquity Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Scott Cutler
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 2.8yrs |
| Board average tenure | 7.4yrs |
Recent management updates
Recent updates
HealthEquity's (NASDAQ:HQY) Returns On Capital Not Reflecting Well On The Business
Dec 04
HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 41% Below Their Intrinsic Value Estimate
Nov 20HealthEquity: High Marks For Recent Profit Growth
Nov 20We Think HealthEquity (NASDAQ:HQY) Can Stay On Top Of Its Debt
Oct 31Getting In Cheap On HealthEquity, Inc. (NASDAQ:HQY) Might Be Difficult
Aug 30HealthEquity: Compelling Catalysts, Fairly Valued, Reiterate Buy
Aug 27Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?
Jul 13We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation
Jun 21Earnings Beat: HealthEquity, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jun 07HealthEquity: A Trading Vehicle Performing As Expected, Strong Growth Hard To Ignore
Jun 04HealthEquity: Strong Growth And Healthy Cash Flows Changed My Mind
May 29Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?
May 03Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues
Apr 11HealthEquity: Multiple Compression Has Finally Made It A Buy
Mar 21HealthEquity Non-GAAP EPS of $0.33 in-line, revenue of $206.1M beats by $2.22M
Sep 06HealthEquity: Asymmetry In Valuation Continues To Widen
Aug 25HealthEquity COO steps down, CEO to assume his responsibilities
Aug 02CEO
Scott Cutler (53 yo)
no data
Tenure
Mr. Scott R. Cutler is CEO, President & Director of HealthEquity, Inc. from January 6, 2025. Mr. Scott R. Cutler serves as an Independent Director of Brookfield Renewable Partners Limited for Brookfield Re...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Vice Chairman | 22.2yrs | US$3.04m | 0.95% $ 84.0m | |
| CFO & Executive VP | 1.3yrs | US$5.23m | 0.011% $ 996.8k | |
| Executive VP & CTO | 2.8yrs | US$4.81m | 0.0042% $ 370.1k | |
| Executive VP | 8.3yrs | US$2.64m | 0.046% $ 4.1m | |
| Director & Special Advisor | no data | US$13.45m | 0.35% $ 31.3m | |
| CEO, President & Director | no data | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| Executive Vice President of Sales & Relationship Management | 3.4yrs | no data | no data | |
| Executive Vice President of Corporate Development & Strategy | 7.8yrs | no data | no data | |
| Executive VP & Chief Marketing Officer | 3yrs | no data | no data | |
| Executive VP & Chief People Officer | 1.8yrs | no data | no data | |
| Senior VP & Head of Product | 2.2yrs | no data | no data |
2.8yrs
Average Tenure
54.5yo
Average Age
Experienced Management: HQY's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Vice Chairman | 22.2yrs | US$3.04m | 0.95% $ 84.0m | |
| Director & Special Advisor | 15.8yrs | US$13.45m | 0.35% $ 31.3m | |
| CEO, President & Director | no data | no data | no data | |
| Independent Director | 8.3yrs | US$297.50k | 0.063% $ 5.6m | |
| Independent Non-Executive Chairman | 9.3yrs | US$362.50k | 0.080% $ 7.1m | |
| Independent Director | 2.3yrs | US$272.50k | 0.0051% $ 450.0k | |
| Independent Director | 10.4yrs | US$290.00k | 0.037% $ 3.3m | |
| Independent Director | 4.1yrs | US$280.00k | 0.0065% $ 579.6k | |
| Independent Director | 7.4yrs | US$278.87k | 0.018% $ 1.6m | |
| Independent Director | 6.8yrs | US$275.00k | 0.0060% $ 536.1k | |
| Independent Director | 2.7yrs | US$272.50k | 0.0097% $ 860.1k |
7.4yrs
Average Tenure
62yo
Average Age
Experienced Board: HQY's board of directors are considered experienced (7.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/21 07:41 |
| End of Day Share Price | 2025/01/21 00:00 |
| Earnings | 2024/10/31 |
| Annual Earnings | 2024/01/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
HealthEquity, Inc. is covered by 24 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mark Marcon | Baird |
| Ishan Majumdar | Baptista Research |
| Alexander Paris | Barrington Research Associates, Inc. |